Response predictors to calcineurin inhibitors in patients with primary membranous nephropathy

X Yu, J Cai, X Jiao, S Zhang, H Liu… - American Journal of …, 2018 - karger.com
Background: Currently, there is an urgent need to find ways of identifying primary
membranous nephropathy (PMN) patients who are likely to benefit from calcineurin …

The clinicopathological features of patients with membranous nephropathy

H Zhu, Q Han, D Zhang, Y Wang, J Gao… - … of Nephrology and …, 2018 - Taylor & Francis
Background Membranous nephropathy (MN) represents a distinct glomerular disease which
has been considered as a major cause of nephrotic syndrome (NS) in adults. Evidences …

Molecular pathogenesis of membranous nephropathy

P Ronco, H Debiec - Annual Review of Pathology: Mechanisms …, 2020 - annualreviews.org
Membranous nephropathy is a noninflammatory autoimmune disease of the kidney
glomerulus, characterized by the formation of immune deposits, complement-mediated …

Gut microbiome analysis can be used as a noninvasive diagnostic tool and plays an essential role in the onset of membranous nephropathy

J Shang, Y Zhang, R Guo, W Liu, J Zhang… - Advanced …, 2022 - Wiley Online Library
Membranous nephropathy (MN) is a common cause of nephrotic syndrome. The aim is to
establish a non‐invasive diagnostic model of MN using differential gut microbiome analysis …

The expanding spectrum and utility of antigens in membranous nephropathy

P Miller, T Caza - Current Opinion in Nephrology and …, 2023 - journals.lww.com
The expanding spectrum and utility of antigens in membranous... : Current Opinion in
Nephrology and Hypertension The expanding spectrum and utility of antigens in membranous …

Detection of PLA2R autoantibodies before the diagnosis of membranous nephropathy

PD Burbelo, M Joshi, A Chaturvedi… - Journal of the …, 2020 - journals.lww.com
Background Circulating serum autoantibodies against the M-type phospholipase A2
receptor (PLA2R-AB) are a key biomarker in the diagnosis and monitoring of primary …

Pathogenesis of membranous nephropathy: a new paradigm in evolution

RJ Glassock - New Insights into Glomerulonephritis, 2013 - karger.com
Membranous nephropathy (MN) has been recognized as a distinct morphological entity for
over 50 years, but it is only recently that the underlying pathogenesis of the primary form of …

Immune system-mediated cellular and molecular mechanisms in idiopathic membranous nephropathy pathogenesis and possible therapeutic targets

R Motavalli, J Etemadi, H Kahroba, A Mehdizadeh… - Life sciences, 2019 - Elsevier
Idiopathic membranous nephropathy (IMN) has recently attracted much attention due to the
development of auto antibodies, anti-phospholipase A2 receptor and anti-thrombospondin …

Hypercholesterolemia correlates with glomerular phospholipase A2 receptor deposit and serum anti-phospholipase A2 receptor antibody and predicts proteinuria …

L Dong, Y Li, S Guo, G Xu, W Wei, M Han - Frontiers in Immunology, 2022 - frontiersin.org
Background The anti-phospholipase A2 receptor (PLA2R) antibody is a non-invasive
diagnostic tool and prognosis predictor of idiopathic membranous nephropathy (IMN) …

Membranous nephropathy: not just a disease for adults

R Ayalon, LH Beck - Pediatric nephrology, 2015 - Springer
Membranous nephropathy (MN) is an immune complex-mediated cause of the nephrotic
syndrome that can occur in all age groups, from infants to the elderly. While systemic …